Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Jia, Yunlong"" wg kryterium: Autor


Tytuł:
NEAT1_1 confers gefitinib resistance in lung adenocarcinoma through promoting AKR1C1-mediated ferroptosis defence
Autorzy:
Zhen, ShumanAff1, Aff2, Aff3
Jia, YunlongAff1, Aff2
Zhao, YanAff1, Aff2, Aff4
Wang, JialiAff1, Aff2
Zheng, Boyang
Liu, TianxuAff1, Aff2
Duan, YuqingAff1, Aff2
Lv, WeiAff1, Aff2
Wang, Jiaqi
Xu, FanAff1, Aff5
Liu, Yueping
Zhang, Yi
Liu, LihuaAff1, Aff2, Aff8, IDs4142002401892w_cor13
Pokaż więcej
Źródło:
Cell Death Discovery. 10(1)
Czasopismo naukowe
Tytuł:
circNOX4 activates an inflammatory fibroblast niche to promote tumor growth and metastasis in NSCLC via FAP/IL-6 axis.
Autorzy:
Zhao Y; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.; Department of Oncology, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China.
Jia Y; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Wang J; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Chen X; Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China.
Han J; Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China.
Zhen S; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Yin S; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Lv W; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Yu F; Department of Thoracic Surgery, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China.
Wang J; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Xu F; Departments of Oncology, The Affiliated Hospital of Chengde Medical University, Chengde, 067000, China.
Zhao X; Department of Nuclear Medicine, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China. .; Hebei Provincial Key Laboratory of Tumor Microenvironment and Drug Resistance, Shijiazhuang, 050011, China. .
Liu L; Department of Tumor Immunotherapy, The Fourth Hospital of Hebei Medical University and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China. .; Cancer Research Institute of Hebei Province, Shijiazhuang, 050011, China. .; International Cooperation Laboratory of Stem Cell Research, Hebei Medical University, Shijiazhuang, 050011, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2024 Mar 08; Vol. 23 (1), pp. 47. Date of Electronic Publication: 2024 Mar 08.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Carcinoma, Non-Small-Cell Lung*/pathology
Lung Neoplasms*/pathology
MicroRNAs*/genetics
MicroRNAs*/metabolism
Cancer-Associated Fibroblasts*/metabolism
Humans ; Interleukin-6/genetics ; Interleukin-6/metabolism ; RNA, Circular/genetics ; RNA, Circular/metabolism ; In Situ Hybridization, Fluorescence ; Fibroblasts ; Cell Line, Tumor ; Cell Proliferation
Czasopismo naukowe
Tytuł:
A Live Cell Protein Complementation Assay for ORFeome-Wide Probing of Human HOX Interactomes.
Autorzy:
Jia Y; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.; Department of Developmental and Cell Biology, University of California, Irvine, CA 92697, USA.
Reboulet J; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.; LiPiCs, 46 Allée d'Italie, 69007 Lyon, France.
Gillet B; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Hughes S; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Forcet C; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Tribollet V; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Hajj Sleiman N; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Kundlacz C; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Vanacker JM; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Bleicher F; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Merabet S; IGFL, CNRS UMR5242, ENS-Lyon, UCBL-1, INRA USC1370, 32 Av. Tony Garnier, 69007 Lyon, France.
Pokaż więcej
Źródło:
Cells [Cells] 2023 Jan 03; Vol. 12 (1). Date of Electronic Publication: 2023 Jan 03.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Protein Interaction Maps*
Humans ; Microscopy, Fluorescence/methods
Czasopismo naukowe
Tytuł:
Near‐Infrared Carbonized Polymer Dots for NIR‐II Bioimaging.
Autorzy:
Han, Tianyang (AUTHOR)
Wang, Yajun (AUTHOR)
Ma, Shengjie (AUTHOR)
Li, Mengfei (AUTHOR)
Zhu, Ningning (AUTHOR)
Tao, Songyuan (AUTHOR)
Xu, Jiajun (AUTHOR)
Sun, Bin (AUTHOR)
Jia, Yunlong (AUTHOR)
Zhang, Yuewei (AUTHOR)
Zhu, Shoujun (AUTHOR)
Yang, Bai (AUTHOR)
Pokaż więcej
Źródło:
Advanced Science. Oct2022, Vol. 9 Issue 30, p1-11. 11p.
Czasopismo naukowe
Tytuł:
Water Inrush Mechanism of Fault Zone in Karst Tunnel under Fluid-Solid Coupling Field considering Effective Stress.
Autorzy:
Huang, Cunhan
Dong, Wenhao
Cao, Zhengzheng
Wang, Yue
An, Gangjian
Chen, Huanqi
Jia, Yunlong
Pan, Qiuyu
Pokaż więcej
Temat:
FAULT zones
KARST
TUNNEL design & construction
ARCHES
TUNNEL lining
WATER seepage
Źródło:
Geofluids; 5/26/2022, p1-11, 11p, 2 Color Photographs, 3 Diagrams, 1 Chart, 3 Graphs
Terminy geograficzne:
CHINA
Czasopismo naukowe
Tytuł:
Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Autorzy:
Jia Y; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Tian C; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Wang H; Department of Thoracic Surgery, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China.
Yu F; Department of Thoracic Surgery, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050011, China.
Lv W; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Duan Y; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Cheng Z; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Wang X; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Wang Y; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Liu T; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Wang J; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China.
Liu L; Department of Tumor Immunotherapy, Hebei Medical University Fourth Affiliated Hospital and Hebei Provincial Tumor Hospital, Shijiazhuang, 050035, China. .; Cancer Research Institute of Hebei Province, Shijiazhuang, 050011, China. .; China International Cooperation Laboratory of Stem Cell Research, Hebei Medical University, Shijiazhuang, 050011, China. .
Pokaż więcej
Źródło:
Molecular cancer [Mol Cancer] 2021 Dec 10; Vol. 20 (1), pp. 162. Date of Electronic Publication: 2021 Dec 10.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Cisplatin/*pharmacology
Drug Resistance, Neoplasm/*drug effects
Esophageal Squamous Cell Carcinoma/*genetics
Esophageal Squamous Cell Carcinoma/*metabolism
Membrane Proteins/*genetics
MicroRNAs/*genetics
RNA, Long Noncoding/*genetics
RNA-Binding Proteins/*genetics
Adult ; Aged ; Animals ; Cell Line, Tumor ; Computational Biology ; Disease Models, Animal ; Esophageal Squamous Cell Carcinoma/drug therapy ; Esophageal Squamous Cell Carcinoma/pathology ; Female ; Gene Expression Profiling ; Gene Expression Regulation, Neoplastic ; Humans ; Male ; Mice ; Middle Aged ; Neoplasm Metastasis ; Neoplasm Staging ; RNA Interference ; ROC Curve ; Xenograft Model Antitumor Assays ; beta Catenin/metabolism
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies